Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women

PLoS ONE

Volumn 5, Issue 12, 2010, Pages 1-10

  Fiehn, Oliver ^a   Timothy Garvey, W ^b   Newman, John W ^a   Lok, Kerry H ^b   Hoppel, Charles L ^c   Adams, Sean H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYBUTYRATE DEHYDROGENASE; 2 OXOISOCAPROIC ACID; ACETYLCARNITINE; BRANCHED CHAIN AMINO ACID; CARBOHYDRATE DERIVATIVE; CYSTINE; HEMOGLOBIN A1C; HISTIDINE; LEUCINE; LONG CHAIN FATTY ACID; VALINE; AMINO ACID; BIOLOGICAL MARKER; GLUCOSE; TRICARBOXYLIC ACID;

AFRICAN AMERICAN; ARTICLE; BLOOD SAMPLING; CITRIC ACID CYCLE; CLINICAL ARTICLE; COMBUSTION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME DEGRADATION; FEMALE; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; METABOLITE; METABOLOMICS; MOLECULE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ALLELE; BLOOD; GENETIC POLYMORPHISM; HOMEOSTASIS; METABOLISM; METHODOLOGY; MISSENSE MUTATION;

ACETYLCARNITINE; AFRICAN AMERICANS; ALLELES; AMINO ACIDS; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; HOMEOSTASIS; HUMANS; METABOLOMICS; MUTATION, MISSENSE; OBESITY; POLYMORPHISM, GENETIC; TRICARBOXYLIC ACIDS;

EID: 78650732495     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015234     Document Type: Article

References (72)

1. Kendall DM, Cuddihy RM, Bergenstal RM (2009) Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use. Am J Med 122: S37-50.
2. McGarry JD (1992) What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258: 766-770.
3. Kusminski CM, Shetty S, Orci L, Unger RH, Scherer PE (2009) Diabetes and apoptosis: lipotoxicity. Apoptosis 14: 1484-1495.
4. Marchesini G, Bianchi GP, Vilstrup H, Capelli M, Zoli M, et al. (1991) Elimination of infused branched-chain amino-acids from plasma of patients with non-obese type 2 diabetes mellitus. Clin Nutr 10: 105-113.
5. Wijekoon EP, Skinner C, Brosnan ME, Brosnan JT (2004) Amino acid metabolism in the Zucker diabetic fatty rat: effects of insulin resistance and of type 2 diabetes. Can J Physiol Pharmacol 82: 506-514.
6. She P, Van Horn C, Reid T, Hutson SM, Cooney RN, et al. (2007) Obesity- related elevations in plasma leucine are associated with alterations in enzymesinvolved in branched-chain amino acid metabolism. Am J Physiol Endocrinol Metab 293: E1552-E1563.
7. Kuzuya T, Katano Y, Nakano I, Hirooka Y, Itoh A, et al. (2008) Regulation of branched-chain amino acid atabolism in rat models for spontaneous type 2 diabetes mellitus. Biochem Biophys Res Commun 373: 94-98.
8. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, et al. (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9: 311-326.
9. Doisaki M, Katano Y, Nakano I, Hirooka Y, Itoh A, et al. (2010) Regulation of hepatic branched-chain alpha-keto acid dehydrogenase kinase in a rat model for type 2 diabetes mellitus at different stages of the disease. Biochem Biophys Res Commun 393: 303-307.
10. Jacob S, Machann J, Rett K, Brechtel K, Volk A, et al. (1999) Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 48: 1113-1119.
11. Krssak M, Falk Petersen K, Dresner A, iPietro L, Vogel S M, et al. (1999) Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42: 113-116.
12. Dobbins RL, zczepaniak L S, Bentley B, Esser V, Myhill J, et al. (2001) Pr olonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats. Diabetes 50: 123-130.
13. McGarry JD (2002) Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51: 7-18.
14. Mingrone G, Rosa G, Greco AV, Manco M, Vega N, et al. (2003) Intramyocitic lipid accumulation and SREBP-1c expression are related to insulin resistance and cardiovascular risk in morbid obesity. Atherosclerosis 170: 155-161.
15. He J, Goodpaster BH, Kelley DE (2004) Effects of weight loss and physical activity on muscle lipid content and droplet size. Obes Res 12: 761-769.
16. Goodpaster BH, Brown NF (2005) Skeletal muscle lipid and its association with insulin resistance: what is the role for exercise? Exerc Sport Sci Rev 33: 150-154.
17. Lara-Castro C, Newcomer BR, Rowell J, Wallace P, Shaughnessy SM, et al. (2008) Effects of short-term very low-calorie diet on intramyocellular lipid and insulin sensitivity in nondiabetic and type 2 diabetic subjects. Metabolism 57: 1-8.
18. Nagle CA, Klett EL, Coleman RA (2009) Hepatic triacylglycerol accumulation and insulin resistance. J Lipid Res 50(Suppl): S74-79.
19. Heilbronn L, Smith SR, Ravussin E (2004) Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int J Obes Relat Metab Disord 28(Suppl 4): S12-21.
20. Lingvay I, Esser V, Legendre JL, Price AL, Wertz KM, et al. (2009) Noninvasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab 94: 4070-4076.
21. Kelley DE (2005) Skeletal muscle fat oxidation: timing and flexibility are everything. J Clin Invest 115: 1699-1702.
22. Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, et al. (2008) Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 7: 45-56.
23. Adams SH, Hoppel CL, Lok KH, Zhao L, Wong SW, et al. (2009) Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. J Nutr 139: 1073-1081.
24. Shulman GI (2004) Unraveling the cellular mechanism of insulin resistance in humans: new insights from magnetic resonance spectroscopy. Physiology (Bethesda) 19: 183-190.
25. Muoio DM, Newgard CB (2008) Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 9: 193-205.
26. Summers SA (2010) Sphingolipids and insulin resistance: the five Ws. Curr Opin Lipidol 21: 128-135.
27. Argyropoulos G, Brown AM, Willi SM, Zhu J, He Y, et al. (1998) Effects of mutations in the human uncoupling protein 3 gene on the respiratory quotient and fat oxidation in severe obesity and type 2 diabetes. J Clin Invest 102: 1345-1351.
28. McLean DC, Jr., Spruill I, Argyropoulos G, Page GP, Shriver MD, et al. (2005) Mitochondrial DNA (mtDNA) haplotypes reveal maternal population genetic affinities of Sea Island Gullah-speaking African Americans. Am J Phys Anthropol 127: 427-438.
29. Fiehn O, Kind T Metabolite profiling in blood plasma (2007) Methods in Molecular Biology 358: 3-17.
30. Sale MM, Lu L, Spruill IJ, Fernandes JK, Lok KH, et al. (2009) Genome-wide linkage scan in Gullah-speaking African American families with type 2 diabetes: the Sea Islands Genetic African American Registry (Project SuGAR). Diabetes 58: 260-267.
31. Divers J, Sale MM, Lu L, Chen WM, Lok KH, et al. (2010) The genetic architecture of lipoprotein subclasses in Gullah-speaking African American families enriched for type 2 diabetes: the Sea Islands Genetic African American Registry (Project SuGAR). J Lipid Res 51: 586-597.
32. Fiehn O, Wohlgemuth G, Scholz M (2005) Setup and annotation of metabolomic experiments by integrating biological and mass spectrometric metadata. Lecture Notes in Computer Science 3615: 224-239.
33. Scholz M, Fiehn O (2007) SetupX-a public study design database for metabolomic projects. Biocomputing 2007, Proceedings of the Pacific Symposium. pp 169-180.
34. Benjamini Y, Hochberg Y (1995) Controlling false discovery rate: a practical and powerful approach to multiple testing. J Royal Statistical Soc., Series B (Methodological), 57: 289-300.
35. Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty- acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785-789.
36. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350: 664-671.
37. Morino K, Falk Petersen K, Dufour S, Befroy D, Frattini J, et al. (2005) Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest 115: 3587-3593.
38. Befroy DE, Falk Petersen K, Dufour S, Mason GF, de Graaf RA, et al. (2007) Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients. Diabetes 56: 1376-1381.
39. Ritov VB, Menshikova EV, He J, Ferrell RE, oodpaster BH, et al. (2005) Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 54: 8-14.
40. Mogensen M, Sahlin K, Fernstrom M, Glintborg D, Vind BF, et al. (2007) Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 56: 1592-1599.
41. Kawasaki T, Akanuma H, Yamanouchi T (2002) Increased fructose concentra- tions in blood and urine in patients with diabetes. Diabetes Care 25: 353-357.
42. Salek RM, aguire M L, Bentley E, Rubtsov D V, Hough T, et al. (2007) A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics 29: 99-108.
43. Li X, Xu Z, Lu X, Yang X, Yin P, et al. (2009) Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: Biomarker discovery for diabetes mellitus. Anal Chim Acta 633: 257-262.
44. Zhang X, Wang Y, Hao F, Zhou X, Han X, et al. (2009) Human serum metabonomic analysis reveals progression axes for glucose intolerance and insulin resistance statuses. J Proteome Res 8: 5188-5195.
45. Zhao X, Fritsche J, Wang J, Chen J, Rittig K, et al. (2010) Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits. Metabolomics 6: 362-374.
46. Gall W E, Beebe K, Lawton K A, Adam K P, Mitchell M W, et al. (2010) alpha- hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One 5: e10883.
47. Elshorbagy AK, Refsum H, Smith AD, Graham IM (2009) The association of plasma cysteine and gamma-glutamyltransferase with BMI and obesity. Obesity 17: 1435-1440.
48. Bajotto G, Murakami T, Nagasaki M, Sato Y, Shimomura Y (2009) Decreased enzyme activity and contents of hepatic branched-chain alpha-keto acid dehydrogenase complex subunits in a rat model for type 2 diabetes mellitus. Metabolism 58: 1489-1495.
49. Huffman KM, Shah SH, Stevens RD, Bain JR, Muehlbauer M, et al. (2009) Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Diabetes Care 32: 1678-1683.
50. Zemel M B (2005) he role of dairy foods in weight management. J Am Coll Nutr 24: 537-546.
51. Nairizi A, She P, Vary TC, Lynch CJ (2009) Leucine supplementation of drinking water does not alter susceptibility to diet-induced obesity in mice. J Nutr 139: 715-719.
52. Zhang Y, Guo K, LeBlanc RE, Loh D, Schwartz GJ, et al. (2007) Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms. Diabetes 56: 1647-1654.
53. Layman D K, Clifton P, Gannon M C, Krauss R M, Nuttall F Q (2008) Protein in optimal health: heart disease and type 2 diabetes. Am J Clin Nutr 87: 1571-1575.
54. Devkota S, Layman DK (2010) Protein metabolic roles in treatment of obesity. Curr Opin Clin Nutr Metab Care 13: 403-407.
55. Pereira S, Marliss EB, Morais JA, Chevalier S, Gougeon R (2008) Insulin resistance of protein metabolism in type 2 diabetes. Diabetes 57: 56-63.
56. Guillet C, Delcourt I, Rance M, Giraudet C, Walrand S, et al. (2009) Changes in basal and insulin and amino acid response of whole body and skeletal muscle proteins in obese men. J Clin Endocrinol Metab 94: 3044-3050.
57. Gougeon R, Pencharz PB, Marliss EB (1994) Effect of NIDDM on the kinetics of whole-body protein metabolism. Diabetes 43: 318-328.
58. Staten MA, Matthews DE, Bier DM (1986) Leucine metabolism in type II diabetes mellitus. Diabetes 35: 1249-1253.
59. Umpleby AM, Scobie IN, Boroujerdi MA, Carson ER, Sonksen PH (1990) Diurnal variation in glucose and leucine metabolism in non-insulin-dependent diabetes. Diabetes Res Clin Pract 9: 89-96.
60. Hoffer LJ, Taveroff A, Hamadeh MJ (1998) Dietary protein restriction alters glucose but not protein metabolism in non-insulin-dependent diabetes mellitus. Metabolism 47: 1145-1151.
61. Halvatsiotis PG, Turk D, Alzaid A, Dinneen S, Rizza RA, et al. (2002) Insulin effect on leucine kinetics in type 2 diabetes mellitus. Diabetes Nutr Metab 15: 136-142.
62. Halvatsiotis P, Short KR, Bigelow M, Nair KS (2002) Synthesis rate of muscle proteins, muscle functions, and amino acid kinetics in type 2 diabetes. Diabetes 51: 2395-2404.
63. Gougeon R, Morais JA, Chevalier S, Pereira S, Lamarche M, et al. (2008) Determinants of whole-body protein metabolism in subjects with and without type 2 diabetes. Diabetes Care 31: 128-133.
64. Fois A, Cioni M, Balestri P, Bartalini G, Baumgartner R, et al. (1986) Biotinidase deficiency: metabolites in CSF. J Inherit Metab Dis 9: 284-285.
65. Baez-Saldana A, Zendejas-Ruiz I, Revilla-Monsalve C, Islas-Andrade S, Cardenas A, et al. (2004) Effects of biotin on pyruvate carboxylase, acetyl- CoA carboxylase, propionyl-CoA carboxylase, and markers for glucose and lipid homeostasis in type 2 diabetic patients and nondiabetic subjects. Am J Clin Nutr 79: 238-243.
66. He J, Watkins S, Kelley DE (2001) Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 50: 817-823.
67. Kelley DE, He J, Menshikova EV, Ritov VB (2002) Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51: 2944-2950.
68. Holloszy J O (2009) Skeletal muscle ''mitochondrial deficiency'' does not mediate insulin resistance. Am J Clin Nutr 89: 463-466.
69. Holloway G P, Bonen A, Spriet L L (2009) Regulation of skeletal muscle mitochondrial fatty acid metabolism in lean and obese individuals. Am J Clin Nutr 89: 455-462.
70. Zoppi CC, Silveira LR, Oliveira CA, Boschero AC, Curi R, et al. (2010) Insulin release, peripheral insulin resistance and muscle function in protein malnutri- tion: a role of tricarboxylic acid cycle anaplerosis. Br J Nutr 103: 1237-1250.
71. Seifert EL, Fiehn O, Bezaire V, Bickel DR, Wohlgemuth G, et al. (2010) Long- chain fatty acid combustion rate is associated with unique metabolite profiles in skeletal muscle mitochondria. PLoS One 5: e9834.
72. Pecqueur C, Couplan E, Bouillaud F, Ricquier D (2001) Genetic and physiological analysis of the role of uncoupling proteins in human energy homeostasis. J Mol Med 79: 48-56.